Agilent Technologies Inc. and the Johannes Kepler University of Linz will sponsor the X. Annual Linz Winter Workshop from Feb. 15-19, 2008, on the University of Linz campus in Austria. The workshop, which has been designed to provide a common platform for industry and academia, will focus on biological single-molecule research, nanoscience, nano-medicine and bio-nanotechnology.
Nanogen, Inc. announced today that it has received stockholder approval on two of the three proposals presented at its special meeting of stockholders on February 1, 2008. The stockholders approved an amendment of the company’s restated certificate of incorporation to increase the number of authorized common shares and to permit the board of directors to effect a reverse stock split at a specific ratio within a range of 1:5 to 1:15, to be determined by the board.
NanoBio Corporation is presenting safety and efficacy results on new topical treatments for herpes labialis (cold sores) and onychomycosis (toe nail fungus) at the annual meeting of the American Academy of Dermatology (AAD), being held February 1-5, 2008, in San Antonio.
Northrop Grumman Corporation and the University of Illinois at Urbana-Champaign have created the first fully-functional, all-carbon nanotube transistor radio, demonstrating that carbon nanotubes can be used as high-speed transistors, while consuming only one-thousandth the power required by current transistor technology.
Piper Jaffray will host its third annual Clean Technology and Renewables Conference Feb. 20, 2008 in New York City. The conference will provide insight on upcoming technological advancements and cost improvements from leading solar, biofuels and other clean technology companies operating across the globe.
CombiMatrix Corporation and Clarient, Inc. today jointly announced establishment of a strategic partnership to market and sell a novel genomics-based cancer test called HemeScan, a comprehensive test related to the treatment and care of chronic lymphocytic leukemia, among other cancers.
D-Wave Systems, developer of quantum computers targeted at commercial applications, has announced the closing of a $17 Million Series C financing. The round was led by International Investment and Underwriting (IIU) of Dublin, Ireland and was strongly supported by existing investors.
Nanogen, Inc., developer of molecular and rapid diagnostic products, announced today that the U.S. Patent and Trademark Office has granted two new patents; No. 7,319,022 titled 'Amplification Methods' and No. 7,297,495 titled 'Hybridization-Triggered Fluorescent Detection Of Nucleic Acids'
Nanometrics provides a complete OCD solution that can measure and model all 45 nm and smaller devices, including scribe line process control targets and advanced die structures, as well as advanced R&D structures for 32 nm and 22 nm nodes, providing the necessary metrology for critical process control.
A needle-free vaccine platform that elicits a robust immune response against a wide array of viruses and bacteria has been awarded a U.S. patent. The University of Michigan holds the patent and NanoBio Corporation, a spin-off from the university, licenses the patent and its associated technology.
Third-Order Nanotechnologies, Inc., a technology company focused on the development of electro-optic polymer materials for applications in high-speed fiber-optic telecommunications and optical computing, has retained TangibleFuture, Inc., a San Francisco based technology analysis and business development consulting company that has substantial expertise in photonics and fiber optic telecommunications.